CURX Curanex Pharmaceuticals Inc Common Stock
Healthcare$0.33+1.07%ClosedMarket Cap: $9.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.16
P/S
0.00
EV/EBITDA
-0.78
DCF Value
$0.18
FCF Yield
-120.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-85.4%
ROA
-86.0%
ROIC
-86.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-3.2M | $-3.2M | $— | — |
| Q4 null | $0.00 | Infinity% | $-3.1M | $-3.1M | $— | — |
| FY null | $0.00 | NaN% | $-4.2M | $-4.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-951.3K | $-954.1K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-57.7K | $-60.3K | $— | — |
| Q1 null | $0.00 | NaN% | $-137.5K | $-137.6K | $— | — |
| Q4 null | $0.00 | NaN% | $-138.6K | $-137.2K | $— | — |
| FY null | $0.00 | NaN% | $-365.1K | $-361.5K | $— | — |
| Q3 null | $0.00 | NaN% | $-102.1K | $-99.9K | $— | — |
| Q2 null | $0.00 | NaN% | $-44.2K | $-44.2K | $— | — |
| Q1 null | $0.00 | NaN% | $-80.2K | $-80.2K | $— | — |
| Q4 2023 | $0.00 | NaN% | $-12.7K | $-12.7K | $-0.00 | — |